A.G. Herman

4.7k total citations · 3 hit papers
105 papers, 3.9k citations indexed

About

A.G. Herman is a scholar working on Physiology, Pharmacology and Molecular Biology. According to data from OpenAlex, A.G. Herman has authored 105 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Physiology, 25 papers in Pharmacology and 23 papers in Molecular Biology. Recurrent topics in A.G. Herman's work include Nitric Oxide and Endothelin Effects (25 papers), Inflammatory mediators and NSAID effects (20 papers) and Eicosanoids and Hypertension Pharmacology (14 papers). A.G. Herman is often cited by papers focused on Nitric Oxide and Endothelin Effects (25 papers), Inflammatory mediators and NSAID effects (20 papers) and Eicosanoids and Hypertension Pharmacology (14 papers). A.G. Herman collaborates with scholars based in Belgium, United Kingdom and United States. A.G. Herman's co-authors include F H Jordaens, Hidde Bult, Paul Pelckmans, Salvador Moncada, John R. Vane, Guy E. Boeckxstaens, Yvan M. Van Maercke, E.A. Higgs, M C Coene and T.J. Verbeuren and has published in prestigious journals such as Nature, Blood and Circulation Research.

In The Last Decade

A.G. Herman

104 papers receiving 3.7k citations

Hit Papers

Nitric oxide as an inhibitory non-adrenergic non-choliner... 1977 2026 1993 2009 1990 1977 1986 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.G. Herman Belgium 30 1.6k 826 796 696 591 105 3.9k
B.J.R. Whittle United Kingdom 25 1.9k 1.2× 681 0.8× 390 0.5× 706 1.0× 647 1.1× 40 3.5k
S. Moncada United Kingdom 19 2.2k 1.4× 651 0.8× 718 0.9× 393 0.6× 653 1.1× 29 3.7k
Kaushik Desai Canada 29 1.7k 1.1× 844 1.0× 837 1.1× 408 0.6× 518 0.9× 57 3.7k
Atsufumi Kawabata Japan 46 2.3k 1.4× 1.6k 2.0× 395 0.5× 596 0.9× 1.2k 2.0× 243 7.2k
Stefano Evangelista Italy 32 714 0.4× 819 1.0× 445 0.6× 512 0.7× 211 0.4× 154 3.1k
Philip I. Aaronson United Kingdom 38 1.7k 1.1× 2.2k 2.7× 938 1.2× 330 0.5× 395 0.7× 114 4.6k
Albert L. Hyman United States 37 1.6k 1.0× 1.1k 1.4× 1.2k 1.5× 650 0.9× 551 0.9× 195 4.4k
S. Jamal Mustafa United States 38 1.5k 0.9× 1.2k 1.5× 1.1k 1.3× 309 0.4× 398 0.7× 170 4.5k
Theodore J. Kalogeris United States 29 726 0.4× 1.8k 2.2× 364 0.5× 949 1.4× 313 0.5× 61 4.7k
H. F. Hodson United Kingdom 16 2.2k 1.4× 736 0.9× 1.0k 1.3× 216 0.3× 664 1.1× 32 3.4k

Countries citing papers authored by A.G. Herman

Since Specialization
Citations

This map shows the geographic impact of A.G. Herman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.G. Herman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.G. Herman more than expected).

Fields of papers citing papers by A.G. Herman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.G. Herman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.G. Herman. The network helps show where A.G. Herman may publish in the future.

Co-authorship network of co-authors of A.G. Herman

This figure shows the co-authorship network connecting the top 25 collaborators of A.G. Herman. A scholar is included among the top collaborators of A.G. Herman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.G. Herman. A.G. Herman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spierings, Julia, Juliëtte Pouw, Harald E. Vonkeman, et al.. (2024). POS0991 THE DEVELOPMENT OF A CLINICAL PREDICTION MODEL FOR TREATMENT RESPONSE IN INDIVIDUAL PSORIATIC ARTHRITIS PATIENTS. Annals of the Rheumatic Diseases. 83. 708–709. 1 indexed citations
2.
Mieghem, W. Van, Jean-Marie Billiouw, Alain Dupont, et al.. (2010). ARE ACE-INHIBITORS OR ARB’S STILL NEEDED FOR CARDIOVASCULAR PREVENTION IN HIGH RISK PATIENTS? INSIGHTS FROM PROFESS AND TRANSCEND. Acta Clinica Belgica. 65(2). 107–114. 1 indexed citations
3.
Filippis, Daniele De, Teresa Iuvone, Alessandra D’Amico, et al.. (2008). Effect of cannabidiol on sepsis‐induced motility disturbances in mice: involvement of CB1receptors and fatty acid amide hydrolase. Neurogastroenterology & Motility. 20(8). 919–927. 68 indexed citations
4.
Martinet, Wim, et al.. (2007). Nitric oxide selectively depletes macrophages in atherosclerotic plaques via induction of endoplasmic reticulum stress. British Journal of Pharmacology. 152(4). 493–500. 19 indexed citations
5.
Winter, Benedicte Y. De, Luc Van Nassauw, Joris G. De Man, et al.. (2005). Role of oxidative stress in the pathogenesis of septic ileus in mice. Neurogastroenterology & Motility. 17(2). 251–261. 55 indexed citations
6.
Martinet, Wim, Guido R.Y. De Meyer, A.G. Herman, & Mark Kockx. (2004). Reactive oxygen species induce RNA damage in human atherosclerosis. European Journal of Clinical Investigation. 34(5). 323–327. 101 indexed citations
7.
Winter, Benedicte Y. De, Joris G. De Man, Tom Seerden, et al.. (2004). Effect of ghrelin and growth hormone‐releasing peptide 6 on septic ileus in mice. Neurogastroenterology & Motility. 16(4). 439–446. 83 indexed citations
8.
Herman, A.G.. (1998). Rationale for the Combination of Anti-Aggregating Drugs. Thrombosis Research. 92(1). S17–S21. 19 indexed citations
9.
Buyssens, N, Mark Kockx, A.G. Herman, et al.. (1996). Centrolobular Liver Fibrosis in the Hypercholesterolemic Rabbit. Hepatology. 24(4). 939–946. 29 indexed citations
11.
Pelckmans, P.A., Guy E. Boeckxstaens, Joris G. De Man, et al.. (1991). Nitric oxide as inhibitory non-adrenergic non-cholinergic neurotransmitter in the gastrointestinal tract. 480. 2 indexed citations
12.
Dam, Peter A. van, et al.. (1989). Prognostic value of prostaglandin F2 alpha concentrations in breast carcinoma.. Journal of Clinical Pathology. 42(10). 1046–1048. 1 indexed citations
13.
Laekeman, Gert, et al.. (1988). In Vitro Study of the Anticholinergic and Antihistaminic Activities of Protopine and Some Derivatives. Journal of Natural Products. 51(5). 1021–1022. 27 indexed citations
14.
Verbeuren, T J, et al.. (1987). CONTRACTIONS TO PLATELETS IN AORTAS OF CONTROL AND CHOLESTEROL-FED RABBITS. Thrombosis and Haemostasis. 2 indexed citations
15.
Bult, Hidde, et al.. (1987). Hydroxy- and hydroperoxy derivatives of linoleic and arachidonic acid suppress the activation of rabbit blood platelets.. PubMed. 17A. 224–8. 4 indexed citations
16.
Verbeuren, T.J., F H Jordaens, L Zonnekeyn, et al.. (1986). Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits.. Circulation Research. 58(4). 552–564. 440 indexed citations breakdown →
17.
Vergote, I., et al.. (1985). Prostaglandin F2α in benign and malignant breast tumours. British Journal of Cancer. 51(6). 827–836. 31 indexed citations
18.
Verbeuren, T J, et al.. (1985). Effects of tertatolol on post- and prejunctional beta adrenoceptors.. Journal of Pharmacology and Experimental Therapeutics. 233(3). 801–809. 11 indexed citations
19.
Verbeuren, T J, F H Jordaens, & A.G. Herman. (1983). Accumulation and release of [3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog.. Journal of Pharmacology and Experimental Therapeutics. 226(2). 579–588. 61 indexed citations
20.
Herman, A.G. & S. Moncada. (1975). Proceedings: Release of prostaglandins and incapacitation after injection of endotoxin in the knee joint of the dog.. British Journal of Pharmacology. 53(3). 465. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026